Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation
- PMID: 25199710
- DOI: 10.1016/j.jaut.2014.08.002
Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation
Abstract
Immune cell infiltration to the brain's territory was considered for decades to reflect a pathological process in which immune cells attack the central nervous system (CNS); such a process is observed in the inflammatory autoimmune disease, multiple sclerosis (MS). As neuroinflammatory processes within the CNS parenchyma are also common to other CNS pathologies, regardless of their etiology, including neurodegenerative disorders such as Alzheimer's disease (AD) and Amyotrophic lateral sclerosis (ALS), these pathologies have often been compared to MS, a disease that benefits from immunosuppressive therapy. Yet, over the last decade, it became clear that autoimmunity has a bright side, and that it plays a pivotal role in CNS repair following damage. Specifically, autoimmune T cells were found to facilitate CNS healing processes, such as in the case of sterile mechanical injuries to the brain or the spinal cord, mental stress, or biochemical insults. Even more intriguingly, autoimmune T cells were found to be involved in supporting fundamental processes of brain functional integrity, such as in the maintenance of life-long brain plasticity, including spatial learning and memory, and neurogenesis. Importantly, autoimmune T cells are part of a cellular network which, to operate efficiently and safely, requires tight regulation by other immune cell populations, such as regulatory T cells, which are indispensable for maintenance of immunological self-tolerance and homeostasis. Here, we suggest that dysregulation of the balance between peripheral immune suppression, on one hand, and protective autoimmunity, on the other, is an underlying mechanism in the emergence and progression of the neuroinflammatory response associated with chronic neurodegenerative diseases and brain aging. Mitigating chronic neuroinflammation under these conditions necessitates activation, rather than suppression, of the peripheral immune response directed against self. Accordingly, we propose that fighting off acute and chronic neurodegenerative conditions requires breaking peripheral immune tolerance to CNS self-antigens, in order to boost protective autoimmunity. Nevertheless, the optimal approach to fine tune such immune response must be individually explored for each condition.
Keywords: Autoimmunity; Neurodegenerative diseases; Neuroinflammation.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS.J Neurosci. 2015 Apr 22;35(16):6381-93. doi: 10.1523/JNEUROSCI.3644-14.2015. J Neurosci. 2015. PMID: 25904790 Free PMC article.
-
Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair.Neuroscientist. 2014 Aug;20(4):343-358. doi: 10.1177/1073858413516799. Epub 2014 Jan 6. Neuroscientist. 2014. PMID: 24395337 Review.
-
CNS inflammation and neurodegeneration.J Clin Invest. 2017 Oct 2;127(10):3577-3587. doi: 10.1172/JCI90609. Epub 2017 Sep 5. J Clin Invest. 2017. PMID: 28872464 Free PMC article.
-
The role of immune-mediated alterations and disorders in ALS disease.Hum Immunol. 2021 Mar;82(3):155-161. doi: 10.1016/j.humimm.2021.01.017. Epub 2021 Feb 12. Hum Immunol. 2021. PMID: 33583639 Free PMC article. Review.
-
ACAID as a potential therapeutic approach to modulate inflammation in neurodegenerative diseases.Med Hypotheses. 2016 Mar;88:38-45. doi: 10.1016/j.mehy.2016.01.006. Epub 2016 Jan 23. Med Hypotheses. 2016. PMID: 26880635 Review.
Cited by
-
Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.PLoS One. 2016 Apr 12;11(4):e0153399. doi: 10.1371/journal.pone.0153399. eCollection 2016. PLoS One. 2016. PMID: 27070121 Free PMC article.
-
Clonal selection versus clonal cooperation: the integrated perception of immune objects.F1000Res. 2016 Sep 5;5:2226. doi: 10.12688/f1000research.9386.1. eCollection 2016. F1000Res. 2016. PMID: 27830060 Free PMC article.
-
Administration of Amyloid Precursor Protein Gene Deleted Mouse ESC-Derived Thymic Epithelial Progenitors Attenuates Alzheimer's Pathology.Front Immunol. 2020 Aug 11;11:1781. doi: 10.3389/fimmu.2020.01781. eCollection 2020. Front Immunol. 2020. PMID: 32849642 Free PMC article.
-
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond.Curr Neuropharmacol. 2024;22(6):1080-1109. doi: 10.2174/1570159X22666231017141636. Curr Neuropharmacol. 2024. PMID: 37898823 Free PMC article.
-
Administration of recombinant FOXN1 protein attenuates Alzheimer's pathology in mice.Brain Behav Immun. 2023 Oct;113:341-352. doi: 10.1016/j.bbi.2023.07.027. Epub 2023 Aug 2. Brain Behav Immun. 2023. PMID: 37541395 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous